Search

You searched for "PRP"

694 results found

Heidelberg Engineering’s Tosh Vadhia announced as new ambassador for Orbis UK

2 January 2026 | charity, international, industry news
Tosh Vadhia, Head of Global Accounts at Heidelberg Engineering joins blindness prevention charity Orbis to help raise awareness of avoidable sight loss. Through Tosh Vadhia’s support, Heidelberg Engineering has played a key role in supporting Orbis’s mission to end avoidable...

Neurofibromatosis type 2 – diagnosis, features and MDT approach

1 December 2021 | | EYE - Orbit, EYE - Vitreo-Retinal, EYE - Cataract, EYE - Refractive, EYE - General
NF2 is a genetic condition caused by mutation in a single gene (NF2 gene) on chromosome 22. The NF2 gene provides instructions to produce a protein called merlin, also known as schwannomin. This protein functions as a tumour suppressor, preventing...

What's trending Apr/May 2023

3 April 2023 | | EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #Cyborgeye #flashlighteye #prostheticeye #BrianStanleyeye Brian Stanley is a California-based engineer, who lost his eye to retinoblastoma when he was six-years-old. A...

Patients blinded by stem cells! How safe are they really?

1 October 2018 | | EYE - Vitreo-Retinal, EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Patients blinded by stem cells! How safe are they really? Ever since the successful results following...

The future of SLT?

2 February 2024 | | EYE - General, EYE - Glaucoma
For Feb/Mar 2024, we are looking at a recently released laser machine to perform direct SLT – selective laser trabeculoplasty (DSLT). Although SLT is well known, DSLT is sufficiently novel that a brief description is a good place to start....

A tale of two membranes

1 February 2016 | | EYE - Vitreo-Retinal
It was the best of times, it was the worst of times... It was the season of Light, it was the season of Darkness... I am fortunate to work on a vitreoretinal firm at the moment and only a few...

Enhancing glaucoma awareness and management in Nigeria – from grass roots to national policy development

5 June 2023 | | EYE - General
This is the second in a series (see Part 1 here) of three articles about strengthening eye health services in Nigeria through collaboration with the LINKS and Networks run at the International Centre for Eye Health, LSHTM. This article highlights...

The assessment of pupils and 
pupillary reactions

1 October 2015 | | EYE - Vitreo-Retinal
Understanding pupillary reactions is vital in understanding basic neuro-opthalmology. It is a skill required in eye casualty, clinics and perhaps most importantly, exams. To start at the beginning, the pupil is the central aperture of the iris, its size controlling...

Is it NAION… Now what?

3 April 2024 | | EYE - Neuro-ophthalmology
Case presentation We present the case and discussion of a 46-year-old Caucasian male who complained of immediate reduced vision following complicated neck dissection including a total laryngopharyngectomy, free flap reconstruction for a T4N3 squamous cell carcinoma (SCC) of the left...

The creation of PlayDoh<sup>®</sup> models as an educational tool for teaching anatomy of the eyelid

1 July 2018 | | EYE - Oculoplastic, EYE - General
An understanding of the anatomy of the eyelid is essential for training in oculoplastic surgery. Active learning has been shown to increase knowledge and retention and has an advantage over passive teaching methods alone [1,2]. PlayDoh® models have been used...

A career in uveitis

7 December 2020 | | EYE - Vitreo-Retinal, EYE - General
As he retires from clinical practice, the author looks back on his long career in uveitis and how care of these patients has changed dramatically since his days as an undergraduate. My trainees and fellows are often bored by my...

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

4 August 2021 | | EYE - Paediatrics, EYE - Vitreo-Retinal, EYE - General
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...